Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Leukemia|December 1, 1995
Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factorsM Montastruc, F X Mahon, C Fabères, et al.
Hematology and Cell Therapy|January 30, 1999
Early infectious complications after bone marrow transplantation requiring medical ICU admissionD Gruson, G Hilbert, C Bébéar, et al.
Bone Marrow Transplantation|July 31, 2001
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patientsO Fitoussi, V Perreau, J M Boiron, et al.
Leukemia & Lymphoma|May 30, 2001
Allogeneic transplantation for patients with advanced acute leukemia: a single center retrospective study of 92 patientsJ M Boiron, D Lerner, A Pigneux, et al.
British Journal of Haematology|November 25, 2003
Adult T-biphenotypic acute leukaemia: clinical and biological features and outcomeM T Rubio, N Dhedin, C Boucheix, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous stem cell transplantation in chronic myeloid leukemia: a single center experienceA Pigneux, C Faberes, J M Boiron, et al.
Bone Marrow Transplantation|May 1, 1996
High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemiaF X Mahon, C Fabères, M Montastruc, et al.
Blood|December 3, 1998
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alphaF X Mahon, C Fabères, S Pueyo, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Pageof 8